Zobrazeno 1 - 5
of 5
pro vyhledávání: '"59"'
Publikováno v:
Transplantation. 83:570-576
BACKGROUND Mycophenolate mofetil (MMF) provides superior prophylaxis against acute rejection when compared with azathioprine (AZA) in heart and renal transplantation. However, it remains unclear whether this results in improved survival or reduced mo
Autor:
Christophe Legendre, Leila Tricot, Evangeline Pillebout, Eric Thervet, Céleste Lebbé, Frank Martinez
Publikováno v:
Transplantation. 80:1546-1549
Background. Immunosuppressive drugs given to solid organ transplant recipients may be responsible for cosmetic side effects which can endanger patient compliance. Cyclosporine is associated with hirsutism whereas tacrolimus has been associated with r
Autor:
John McMichael, John J. Fung, Thomas E. Starzl, Anthony J. Demetris, George V. Mazariegos, Ignazio R. Marino, Bridget Flynn, William Irish, Jorge Reyes
Publikováno v:
Transplantation. 63:243-249
Immunosuppression has been sporadically discontinued by noncompliant liver allograft recipients for whom an additional 4 1/2 years of follow-up is provided. These anecdotal observations prompted a previously reported prospective drug withdrawal progr
Autor:
Miguel, Gonzalez Molina, Daniel, Seron, Raimundo, Garcia del Moral, Marta, Carrera, Eugenia, Sola, Maria, Jesus Alferez, Pablo, Gomez Ullate, Luis, Capdevila, Miguel A, Gentil
Publikováno v:
Transplantation. 77(2)
Although studies have shown that mycophenolate mofetil (MMF) with cyclosporine (CsA) and prednisone can reduce the incidence of acute rejection and increase the half-life of the graft, the effects of MMF on established chronic allograft nephropathy (
Publikováno v:
Transplantation. 47(2)
Inducing immunosuppression in heart transplant patients with intravenous doses of CsA may decrease the incidence of severe rejection in the 1st month after operation. In our initial series, 16 consecutive patients (group A) who had no contraindicatio